Optura, a healthcare technology company focused on measuring and optimizing AI investment performance, announced a $17.5 million Series A led by Salesforce Ventures, with participation from Echo Health Ventures, Susa Ventures, Matrix Partners, and HC9 Ventures. The round brings the company’s total funding to more than $25 million.
The investment follows growing enterprise demand for platforms that help healthcare organizations evaluate AI impact, prioritize use cases, and track measurable business outcomes.
Addressing AI Accountability In Healthcare
Optura’s ROAI™ platform is designed to help healthcare providers and health plans assess AI investments before deployment and monitor operational performance in real time.
“The hundreds of AI use cases coupled with the introduction of foundational models into healthcare markets, like Claude for Healthcare, are driving AI spend and increasing risk,” said Andy Fanning, Co-Founder and CEO of Optura. “We developed Optura to take out that guesswork and help healthcare organizations objectively measure results.”
The company stated that healthcare organizations are rapidly increasing AI spending despite limited measurable returns from many enterprise AI pilots.
Platform Growth And Enterprise Adoption
Since launching last year, Optura has gained adoption among enterprise healthcare organizations including Independence Blue Cross, Prime Therapeutics, and Ardent Health.
According to the company, more than $2 billion in AI initiatives are currently managed through the platform, with over $120 million in tracked value and more than 250 identified AI use cases.
The platform enables organizations to map fragmented data into a unified system, prioritize AI opportunities, simulate projected returns, and monitor deployment outcomes through a centralized dashboard.
Expanding AI Infrastructure And Partnerships
The new funding will support platform expansion, AI capability development, and additional LLM partnerships.
“Healthcare organizations are under growing pressure to move beyond AI experimentation and deliver measurable business outcomes,” said Katie Thiry, Managing Director at Salesforce Ventures.
“Optura is solving one of our industry’s biggest challenges: helping healthcare organizations structure and capture real value from AI programs,” added Kurt Sheline, Partner at Echo Health Ventures.